Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Immutep Ltd ADR (IMMP)

Immutep Ltd ADR (IMMP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Immutep Ltd ADR LEVEL 32 SUITE 32.07 AUSTRALIA SQUARE 264 GEORGE STREET SYDNEY C3 2000 AUS

www.immutep.com Employees: 44 P: 61-2-8315-7003 F: +61 285691880

Description:

Immutep Limited is a biotechnology company. It engaged in developing novel immunotherapy treatments for cancer and autoimmune disease. The company's product pipeline consists of eftilagimod alpha, IMP731, IMP701 and IMP761 which are in clinical stage. It operates primarily in Europe, Australia and the U.S. Immutep Limited, formerly known as Prima BioMed Ltd, is headquartered in Sydney, Australia.

Key Statistics

Overview:

Market Capitalization, $K 267,641
Enterprise Value, $K 161,541
Shares Outstanding, K 145,457
Annual Sales, $ 5,140 K
Annual Net Income, $ -28,010 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -3,075 K
EBIT, $ 0 K
EBITDA, $ -26,450 K
60-Month Beta 2.20
% of Insider Shareholders 3.07%
% of Institutional Shareholders 2.32%
Float, K 140,991
% Float 96.93%
Short Volume Ratio 0.31

Growth:

1-Year Return 2.39%
3-Year Return -45.88%
5-Year Return 5.75%
5-Year Revenue Growth -4.10%
5-Year Earnings Growth 43.90%
5-Year Dividend Growth 0.00%

Per-Share Information:

Next Earnings Date 10/05/23
Earnings Per Share ttm 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 3-10 on 12/28/16

IMMP Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % 0.00%
Return-on-Assets % 0.00%
Profit Margin % -544.94%
Debt/Equity 0.00
Price/Sales 55.47
Price/Cash Flow N/A
Price/Book 1.87
Book Value/Share 1.05
Interest Coverage -3.80
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar